CLT-002

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCLT-002
Drug Alias NameKallikrein Inhibitor/Kallistatin (Charlesson)CLT-002
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionKallikreins inhibitors
TargetsKallikreins
Therapy Area/IndicationsDiabetic NephropathiesDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCharlesson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCharlesson
Active IndicationsN/A
Inactive IndicationsDiabetic NephropathiesDiabetic Retinopathy

Other Information

ATC CodeN/A
Related LinksN/A